TH (Ab-19) Antibody

What is the TH (Ab-19) Antibody and what specific epitope does it recognize?

TH (Ab-19) Antibody is a rabbit polyclonal antibody that specifically recognizes Tyrosine Hydroxylase (TH) around the phosphorylation site of serine 19. It was developed using a synthesized non-phosphopeptide derived from Human Tyrosine Hydroxylase with the sequence A-V-S(p)-E-Q . This antibody is particularly valuable for studying the phosphorylation state of TH, which is critical for understanding regulatory mechanisms of catecholamine synthesis in neurological research.

What applications is the TH (Ab-19) Antibody validated for in research settings?

The antibody has been validated for multiple research applications including:

• Western blotting (WB) at dilutions of 1:500-1:3000

• Immunohistochemistry on paraffin-embedded tissues (IHC-P) at dilutions of 1:50-1:100

• Immunofluorescence (IF) at dilutions of 1:100-1:500

• Enzyme-linked immunosorbent assay (ELISA)

Research has demonstrated successful application in various neural tissue studies, showing specific staining patterns in human brain tissue, as well as in cell line models such as 3T3 cells and HuvEc cells.

What standardized protocols should be followed for optimal results with TH (Ab-19) Antibody in different applications?

For optimal results across applications, researchers should follow these methodological guidelines:

For Western Blot (WB):

• Use freshly prepared samples in RIPA buffer with phosphatase inhibitors

• Load 20-40 μg protein per lane

• Transfer to PVDF membrane (preferred over nitrocellulose for phospho-epitopes)

• Block with 5% BSA (not milk) in TBST for 1 hour at room temperature

• Incubate with primary antibody (1:1000 dilution recommended as starting point) overnight at 4°C

• Wash 3x with TBST

• Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature

• Develop using enhanced chemiluminescence

For Immunohistochemistry:

• Use 4-6 μm paraffin sections

• Perform heat-mediated antigen retrieval in citrate buffer (pH 6.0)

• Block endogenous peroxidase activity with 3% H₂O₂

• Block with 5% normal goat serum

• Incubate with primary antibody (1:50-1:100) overnight at 4°C

• Follow with appropriate detection system

Similar to procedures described in research on neural antibodies , proper validation controls are essential for all applications.

How should researchers approach antibody validation for TH (Ab-19) in their specific experimental contexts?

Antibody validation should follow a multi-step approach as recommended by authorities in antibody characterization :

• Knockout/knockdown validation: Test the antibody in samples where TH expression is genetically eliminated or reduced

• Phosphorylation-state specificity: Compare binding to phosphorylated versus non-phosphorylated peptides

• Cross-reactivity testing: Evaluate binding to other phosphorylated proteins, particularly those with similar sequence motifs around Ser/Thr sites

• Independent method correlation: Correlate results with other detection methods (e.g., mass spectrometry)

• Application-specific validation: Validate separately for each application (WB, IHC, IF, ELISA)

Researchers should document validation results comprehensively as emphasized in recent literature on antibody standardization .

How specific is the TH (Ab-19) Antibody to the Ser19 phosphorylation site, and what cross-reactivities should researchers be aware of?

• Other phosphorylation sites on TH (Ser8, Ser31, Ser40) that may have similar surrounding sequences

• Phosphorylated epitopes on other proteins with similar sequence motifs

Cross-reactivity testing is recommended via:

• Peptide competition assays using phosphorylated and non-phosphorylated peptides

• Comparison with other well-characterized anti-TH antibodies

• Testing on samples with known phosphorylation states

This approach mirrors the rigorous characterization methods employed in studies of neutralizing antibodies, where epitope specificity is critical .

What controls should be included when working with TH (Ab-19) Antibody to ensure result validity?

To ensure valid experimental results, researchers should include the following controls:

• Positive control: Tissue or cell lysate known to express phosphorylated TH (e.g., adrenal medulla, PC12 cells treated with forskolin)

• Negative control:

  • Primary antibody omission

  • Tissue/cells lacking TH expression (e.g., non-neuronal tissues)

  • Samples treated with phosphatase

• Peptide competition control: Pre-incubate antibody with excess immunizing peptide

• Phosphorylation state controls: Compare samples with different phosphorylation states (e.g., stimulated vs. unstimulated neurons)

• Secondary antibody control: Apply only secondary antibody to test for non-specific binding

These controls align with established practices in neuroimmunology research and help distinguish true signal from background.

How can TH (Ab-19) Antibody be effectively used in multiplexed immunoassays with other neural markers?

For effective multiplexing with TH (Ab-19) Antibody:

• Antibody compatibility testing:

  • Ensure primary antibodies are from different host species or different isotypes

  • Test for cross-reactivity between secondary antibodies

  • Conduct sequential rather than simultaneous staining if cross-reactivity is observed

• Fluorophore selection for IF multiplexing:

  • Choose fluorophores with minimal spectral overlap

  • Include single-stain controls to determine bleed-through

  • Consider tyramide signal amplification for weak signals

• Validated multiplex combinations:

  • TH (Ab-19) + neuronal markers (NeuN, MAP2)

  • TH (Ab-19) + other catecholaminergic markers (DBH, AADC)

  • TH (Ab-19) + glial markers (GFAP, Iba1) for neuroinflammation studies

This approach follows principles employed in complex immunofluorescence studies as referenced in publications on neural antibody characterization .

How does the phosphorylation state of TH affect the binding specificity of TH (Ab-19) Antibody, and how can this be leveraged in studies of neuronal signaling?

The binding specificity of TH (Ab-19) can be utilized to study neuronal signaling through:

• Differential phosphorylation analysis:

  • The antibody recognizes the region around Ser19 but was not designed to be phospho-specific

  • Comparison with phospho-specific antibodies can reveal phosphorylation dynamics

  • Treat samples with phosphatases to confirm phosphorylation-dependent signals

• Signaling pathway investigations:

  • Monitor TH phosphorylation in response to pathway activators/inhibitors

  • Use in conjunction with phospho-specific antibodies against Ser40 to study PKA-mediated regulation

  • Compare with antibodies against Ser31 for ERK-mediated regulation

• Quantitative applications:

  • Densitometric analysis of Western blots to quantify relative phosphorylation levels

  • Flow cytometry to assess neuronal subpopulations with different phosphorylation states

  • Proximity ligation assays to detect TH interactions with kinases/phosphatases

These approaches build on methodologies established for studying protein phosphorylation dynamics in complex biological systems.

What are common issues encountered with TH (Ab-19) Antibody and how can they be resolved?

These troubleshooting approaches follow standard principles of antibody optimization in immunological research .

How can researchers optimize signal-to-noise ratio when using TH (Ab-19) Antibody in challenging samples like human brain tissue?

For optimal signal-to-noise ratio in challenging samples:

• Sample preparation optimization:

  • For human brain tissue: Fix in 4% PFA for 24-48h maximum

  • Process tissue promptly after collection

  • For archived samples: Extended antigen retrieval (20-30 min) may be necessary

• Signal amplification strategies:

  • TSA (Tyramide Signal Amplification) for IF and IHC

  • Biotin-Streptavidin systems for enhanced detection

  • Super-resolution microscopy techniques for detailed localization

• Background reduction techniques:

  • Pre-adsorption of antibody with brain homogenate from non-target species

  • Inclusion of detergents (0.3% Triton X-100) to reduce non-specific membrane binding

  • Use of specialized blocking agents containing both proteins and small molecules

• Autofluorescence management (for IF):

  • Sudan Black B treatment (0.1% in 70% ethanol) for 10 minutes

  • Photobleaching with strong illumination before antibody application

  • Spectral unmixing during image acquisition

These approaches reflect advanced techniques used in neuroscience research for challenging tissues, similar to methodologies referenced in studies of neural antibodies .

How can TH (Ab-19) Antibody be utilized to study neurodegenerative disorders involving catecholaminergic systems?

The TH (Ab-19) Antibody can be applied to neurodegenerative disease research through:

• Parkinson's Disease studies:

  • Quantification of TH+ neurons in substantia nigra using stereological methods

  • Assessment of phosphorylation state changes in remaining dopaminergic neurons

  • Correlation of TH phosphorylation with α-synuclein pathology

• Animal models of neurodegeneration:

  • Time-course analysis of TH phosphorylation in MPTP, 6-OHDA, or α-synuclein overexpression models

  • Evaluation of neuroprotective treatments on TH phosphorylation maintenance

  • Co-localization studies with oxidative stress markers

• Human post-mortem tissue applications:

  • Comparison of TH phosphorylation patterns between control and diseased brain regions

  • Analysis of correlation between TH phosphorylation and disease progression markers

  • Investigation of compensatory mechanisms in surviving neurons

These approaches align with current methodologies in neurodegenerative disease research and utilize the antibody within standardized protocols similar to those described for neural antibody applications .

What considerations should be made when using TH (Ab-19) Antibody for comparative studies across different species?

When conducting cross-species comparisons:

• Species reactivity validation:

  • Despite reported reactivity with human, mouse, and rat , independently validate in each species

  • Test at multiple dilutions to determine optimal concentration for each species

  • Compare staining patterns with published TH distribution in target species

• Epitope conservation assessment:

  • The Ser19 region of TH is highly conserved across mammals but verify sequence homology

  • Consider potential species differences in post-translational modifications

  • Analyze species-specific phosphorylation kinetics

• Fixation and processing adjustments:

  • Optimize fixation time for different species (generally shorter for rodents than human tissue)

  • Adjust antigen retrieval conditions based on tissue density

  • Use species-matched positive controls for each experiment

• Data interpretation guidelines:

  • Account for species differences in catecholaminergic system organization

  • Consider evolutionary differences in TH regulation when interpreting phosphorylation patterns

  • Use quantitative approaches with species-specific normalization standards

These considerations reflect best practices in comparative neuroscience and build on principles established for cross-species antibody applications.

How can TH (Ab-19) Antibody be combined with other methodologies to provide comprehensive insights into neural circuit function?

Integration of TH (Ab-19) Antibody with complementary methodologies offers powerful experimental approaches:

• Combination with electrophysiology:

  • Post-recording immunolabeling of patched neurons to correlate TH phosphorylation with activity

  • Analysis of phosphorylation state in neurons with different firing patterns

  • Bath application of modulators followed by fixation and immunostaining

• Integration with optogenetic manipulations:

  • Targeting of channelrhodopsin to TH+ neurons followed by stimulation and Ab-19 staining

  • Correlation of stimulation parameters with phosphorylation changes

  • Circuit mapping of inputs that modulate TH phosphorylation

• CLARITY and volumetric imaging applications:

  • Whole-brain mapping of TH phosphorylation patterns

  • 3D reconstruction of intact catecholaminergic systems

  • Registration to brain atlases for standardized analysis

• Single-cell transcriptomics correlation:

  • Patch-seq approaches combining electrophysiology, transcriptomics and TH (Ab-19) immunolabeling

  • Correlation of gene expression profiles with phosphorylation states

  • Identification of molecular markers associated with different phosphorylation patterns

These integrative approaches follow advanced experimental paradigms in contemporary neuroscience research.

What experimental design strategies can help resolve contradictory results when using TH (Ab-19) Antibody in complex neural tissues?

To resolve contradictory results:

• Orthogonal methodology validation:

  • Confirm antibody findings with independent techniques (e.g., mass spectrometry)

  • Apply genetic approaches (CRISPR, RNAi) to validate antibody specificity

  • Use multiple antibodies targeting different TH epitopes

• Comprehensive controls framework:

  • Include tissue from TH knockout animals as negative controls

  • Use phosphatase-treated samples to confirm phosphorylation specificity

  • Employ peptide competition with both phosphorylated and non-phosphorylated peptides

• Systematic parameter variation:

  • Test multiple fixation protocols (PFA, methanol, acetone)

  • Compare different antigen retrieval methods (heat vs. enzymatic)

  • Evaluate protocol-dependent variations in staining patterns

• Statistical robustness enhancements:

  • Increase biological replicates (n≥5 animals)

  • Use blinded quantification by multiple observers

  • Apply machine learning algorithms for unbiased pattern recognition

• Data integration approach:

  • Generate comprehensive datasets across multiple experimental conditions

  • Develop mathematical models to explain apparently contradictory results

  • Consider stoichiometric relationships between phosphorylation sites

This systematic approach reflects best practices for resolving contradictory findings in antibody-based research and incorporates principles of rigorous experimental design.

How do recombinant antibody technologies compare to traditional polyclonal antibodies like TH (Ab-19) for neural research applications?

Comparison of traditional polyclonal antibodies like TH (Ab-19) with recombinant technologies reveals important distinctions:

The field is moving toward recombinant antibodies as exemplified by initiatives like NeuroMab, which is converting hybridoma-based monoclonal antibodies to recombinant formats with publicly available sequences . This trend represents a significant advance in addressing the "antibody reproducibility crisis" in neuroscience research.

What emerging methodologies could enhance the utility of TH (Ab-19) Antibody for studying neural development and plasticity?

Emerging methodologies with potential to enhance TH (Ab-19) Antibody applications include:

• Super-resolution microscopy integration:

  • STORM/PALM techniques for nanoscale localization of TH phosphorylation

  • Expansion microscopy to physically enlarge samples for enhanced resolution

  • Correlative light-electron microscopy to relate phosphorylation to ultrastructure

• Live-cell phosphorylation monitoring:

  • Development of membrane-permeant antibody derivatives

  • Conversion to recombinant intrabodies for in vivo expression

  • FRET-based sensors incorporating Ab-19 binding domains

• Spatial transcriptomics correlation:

  • Combining TH immunolabeling with in situ sequencing

  • Mapping phosphorylation states to transcriptional profiles

  • Identifying spatial domains with distinct regulatory mechanisms

• Advanced tissue clearing approaches:

  • Optimization of CLARITY, iDISCO and CUBIC protocols for TH phosphorylation preservation

  • Whole-organism mapping of catecholaminergic systems during development

  • 4D analysis of phosphorylation changes during critical developmental periods

• AI-assisted image analysis:

  • Deep learning algorithms for automated quantification of phosphorylation patterns

  • Classification of neuronal subtypes based on phosphorylation signatures

  • Predictive modeling of phosphorylation responses to pharmacological interventions